Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)

Watchlist
0.150
-0.005-3.23%
Close  02/08 16:00 ET
High
0.175
Open
0.150
Turnover
1.19K
Low
0.150
Pre Close
0.155
Volume
7.87K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.800
Shares
0
P/E(Static)
0.00
52wk Low
0.016
Float Cap
0
Bid/Ask %
75.00%
Historical High
2.240
Shs Float
0
Volume Ratio
0.43
Historical Low
0.016
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
16.07%
Avg Price
0.151
Lot Size
1
Float Cap
0
Bid/Ask %
75.00%
Historical High
2.240
Shs Float
0
Volume Ratio
0.43
Historical Low
0.016
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
16.07%
Avg Price
0.151
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
CEO: Mr. Ronald A. Martell
Market: NASDAQ
Listing Date: 01/10/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist